EUVIMEDEUVIMED entdecken
Crossref

An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease

Yanling Wang, Chi Zhang, Tong Liu, Qingsong Li, Xue Guan, Yutian Hu, Bo Cao, Xiaohong Wu, Qin Zhou, Feiyun Cui

Analytica Chimica Acta · 2026-08 · 1411 · 345637

DOI: 10.1016/j.aca.2026.345637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-08. Verfasst von Yanling Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China; The Heilongjiang Provincial Joint Laboratory of Basic Medicine an…. Hauptthemen laut MEDLINE: Alzheimer Disease, Spectrum Analysis, Raman, Metabolomics, Artificial Intelligence. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Heilongjiang Province Natural Science Foundation, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Label-free surface-enhanced Raman spectroscopy (SERS) offers a promising avenue for rapid metabolic phenotyping in complex biofluids, yet its translational potential is hindered by the challenge of deconvoluting overlapping spectral contributions and identifying specific metabolite signatures. Herein, we report a liquid chromatography-mass spectrometry (LC-MS)-guided AI enabled serum molecule-interpretable SERS Platform, termed AMI-SERS, which integrates SERS, untargeted metabolomics and machine learning (ML) for Alzheimer's disease (AD) patient serum exploratory metabolic profiling. ML has achieved excellent classification performance with an accuracy of 96.67% under leave-one-out cross-validation. A novel multi-source matching algorithm was devised to trace dominant spectral features directly to specific metabolite changes, uncovering hypoxanthine as a key pre-analytical confounder and nominating adenine as a potential AD biomarker. However, due to the limited sample size, these results are only applicable to exploratory analysis. In conclusion, the AMI-SERS platform establishes a molecular-resolvable, LC-MS-interpretable AI methodological framework for exploratory serum metabolomics and its clinical applicability requires large-scale independent validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSpectrum Analysis, RamanMetabolomicsArtificial IntelligenceHumansLiquid Chromatography-Mass SpectrometryMachine LearningBiomarkersChromatography, Liquid

Stichwörter der Autor:innen

Alzheimer's disease (AD)Machine learning (ML)Metabolism analysisSurface-enhanced Raman spectroscopy (SERS)

Substanzen

Biomarkers

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Harbin Medical University, Harbin, 150081, China; The Heilongjiang Provincial Joint Laboratory of Basic Medicine and Multiple Organ System Diseases (International Cooperation), Harbin,…
  • Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China.
  • NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China. Electronic address: wuxiaohong@hrbmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Heilongjiang Province Natural Science Foundation
  • National Key Research and Development Program of China

Zitieren

APA

Wang, Y., Zhang, C., Liu, T., Li, Q., Guan, X., Hu, Y., Cao, B., Wu, X., Zhou, Q., & Cui, F. (2026). An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease. Analytica Chimica Acta, 1411, 345637. https://doi.org/10.1016/j.aca.2026.345637

Vancouver

Wang Y, Zhang C, Liu T, Li Q, Guan X, Hu Y, et al. An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease. Analytica Chimica Acta. 2026;1411:345637. doi:10.1016/j.aca.2026.345637

BibTeX
@article{Wang2026,
  author = {Wang, Yanling and Zhang, Chi and Liu, Tong and Li, Qingsong and Guan, Xue and Hu, Yutian and Cao, Bo and Wu, Xiaohong and Zhou, Qin and Cui, Feiyun},
  title = {An LC-MS–guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease},
  journal = {Analytica Chimica Acta},
  year = {2026},
  volume = {1411},
  pages = {345637},
  doi = {10.1016/j.aca.2026.345637}
}
Kostenlos starten →